| Product Code: ETC11390197 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Latvia saw a steady increase in antidepressants import shipments with a Compound Annual Growth Rate (CAGR) of 8.6% from 2020 to 2024. The top exporting countries to Latvia included Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the growth, the Herfindahl-Hirschman Index (HHI) indicated low market concentration in 2024. The growth rate from 2023 to 2024 stood at a healthy 7.03%, reflecting sustained demand for antidepressants in Latvia. This data suggests a competitive market landscape with diverse sources of imports contributing to meeting the country`s antidepressant needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Antidepressants Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Antidepressants Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Antidepressants Market - Industry Life Cycle |
3.4 Latvia Antidepressants Market - Porter's Five Forces |
3.5 Latvia Antidepressants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Antidepressants Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.7 Latvia Antidepressants Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
4 Latvia Antidepressants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health issues and the importance of seeking treatment. |
4.2.2 Growing acceptance of mental health disorders and reduction of stigma associated with antidepressant use. |
4.2.3 Rise in the prevalence of depression and anxiety disorders in Latvia. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new antidepressant drugs. |
4.3.2 Side effects and potential risks associated with antidepressant medications. |
4.3.3 Limited access to mental health professionals and resources in certain regions of Latvia. |
5 Latvia Antidepressants Market Trends |
6 Latvia Antidepressants Market, By Types |
6.1 Latvia Antidepressants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Antidepressants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Antidepressants Market Revenues & Volume, By Prescription, 2021 - 2031F |
6.1.4 Latvia Antidepressants Market Revenues & Volume, By Over-the-Counter, 2021 - 2031F |
6.2 Latvia Antidepressants Market, By Formulation |
6.2.1 Overview and Analysis |
6.2.2 Latvia Antidepressants Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.2.3 Latvia Antidepressants Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.2.4 Latvia Antidepressants Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.3 Latvia Antidepressants Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Latvia Antidepressants Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Latvia Antidepressants Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Latvia Antidepressants Market Revenues & Volume, By Geriatric, 2021 - 2031F |
7 Latvia Antidepressants Market Import-Export Trade Statistics |
7.1 Latvia Antidepressants Market Export to Major Countries |
7.2 Latvia Antidepressants Market Imports from Major Countries |
8 Latvia Antidepressants Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns and initiatives launched in Latvia. |
8.2 Percentage increase in the number of individuals seeking treatment for depression and anxiety. |
8.3 Rate of adoption of telemedicine and online mental health services in Latvia. |
8.4 Patient adherence and persistence rates for antidepressant medications in Latvia. |
8.5 Number of reported adverse events related to antidepressant use in Latvia. |
9 Latvia Antidepressants Market - Opportunity Assessment |
9.1 Latvia Antidepressants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Antidepressants Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.3 Latvia Antidepressants Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
10 Latvia Antidepressants Market - Competitive Landscape |
10.1 Latvia Antidepressants Market Revenue Share, By Companies, 2024 |
10.2 Latvia Antidepressants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here